Search NASA⌕ Search

Engineering topics

Holmes, C

Publications and source records attributed to Holmes, C.

MO-F-16A-05: Spot-Scanning Proton Therapy Patient-Specific Quality Assurance: Our Methodology and Results From 295 Treatment Plans

Purpose: To report on the patient-specific quality assurance (PSQA) results for 295 spot-scanning proton therapy treatment plans from the MD Anderson PTC-Houston. We show how the results differed by treatment site and how they were affected by the treatment plan optimization method and by a range shifter in the treatment field. We also discuss some causes of PSQA problems. Methods: The PSQA procedure, which is designed to verify both the accuracy of the treatment planning system's (Eclipse™ v8.9) dose calculations and the dose delivery of the Hitachi PROBEAT synchrotron, consists of (1) an end-to-end test in which the beam is delivered and measured at the prescribed gantry angle, and (2) additional dose plane measurements made from gantry angle 270°. HPlusQA™ software automatically performs the gamma analysis with criteria 3% (dose tolerance), 3 mm (distance-to-agreement, DTA) and 2%, 2 mm. Passing is defined as at least 90% of the pixels having a gamma score less than 1. Results: The PSQA gamma passing rate was 96.2% for 3%, 3 mm, and 85.3% for 2%, 2 mm. The rate depended on the treatment site. For example, the 3%, 3 mm passing rate was 95% for head and neck plans, vs 100% for prostate plans. The passing rates of multi- vs. single-field optimization plans did not significantly differ. However, the rate for fields with range shifters was 94.8±0.6%, vs 99.0±0.6% for those without (p = 0.002). Longitudinal dose gradients caused most of the low scores. Overestimation of the calculated dose proximal to the spread-out Bragg peak (SOBP) caused many of the others. Conclusion: The planned and delivered doses consistently agreed within tolerance levels. Minor dose modeling deficiencies remain proximal to the SOBP. The 3% dose tolerance, 3 mm DTA, with 90% pixel passing rate is a reasonable action level for 2D gamma comparisons.

60 APPLIED LIFE SCIENCES↗

ULTRA-COMPACT ACCELERATOR TECHNOLOGIES FOR APPLICATION IN NUCLEAR TECHNIQUES

We report on compact accelerator technology development for potential use as a pulsed neutron source quantitative post verifier. The technology is derived from our on-going compact accelerator technology development program for radiography under the US Department of Energy and for a clinic sized compact proton therapy systems under an industry sponsored Cooperative Research and Development Agreement. The accelerator technique relies on the synchronous discharge of a prompt pulse generating stacked transmission line structure with the beam transit. The goal of this technology is to achieve approx10 MV/m gradients for 10 s of nanoseconds pulses and approx100 MV/m gradients for approx1 ns systems. As a post verifier for supplementing existing x-ray equipment, this system can remain in a charged, stand-by state with little or no energy consumption. We describe the progress of our overall component development effort with the multilayer dielectric wall insulators (i.e., the accelerator wall), compact power supply technology, kHz repetition-rate surface flashover ion sources, and the prompt pulse generation system consisting of wide-bandgap switches and high performance dielectric materials.

43 PARTICLE ACCELERATORS↗

Compact Dielectric Wall Accelerator Development For Intensity Modulated Proton Therapy And Homeland Security Applications

Compact dielectric wall (DWA) accelerator technology is being developed at the Lawrence Livermore National Laboratory. The DWA accelerator uses fast switched high voltage transmission lines to generate pulsed electric fields on the inside of a high gradient insulating (HGI) acceleration tube. Its high electric field gradients are achieved by the use of alternating insulators and conductors and short pulse times. The DWA concept can be applied to accelerate charge particle beams with any charge to mass ratio and energy. Based on the DWA system, a novel compact proton therapy accelerator is being developed. This proton therapy system will produce individual pulses that can be varied in intensity, energy and spot width. The system will be capable of being sited in a conventional linac vault and provide intensity modulated rotational therapy. The status of the developmental new technologies that make the compact system possible will be reviewed. These include, high gradient vacuum insulators, solid dielectric materials, SiC photoconductive switches and compact proton sources. Applications of the DWA accelerator to problems in homeland security will also be discussed.

43 PARTICLE ACCELERATORS↗

STATUS OF THE DIELECTRIC WALL ACCELERATOR

The dielectric wall accelerator (DWA) system being developed at the Lawrence Livermore National Laboratory (LLNL) uses fast switched high voltage transmission lines to generate pulsed electric fields on the inside of a high gradient insulating (HGI) acceleration tube. High electric field gradients are achieved by the use of alternating insulators and conductors and short pulse times. The system is capable of accelerating any charge to mass ratio particle. Applications of high gradient proton and electron versions of this accelerator will be discussed. The status of the developmental new technologies that make the compact system possible will be reviewed. These include, high gradient vacuum insulators, solid dielectric materials, photoconductive switches and compact proton sources.

43 PARTICLE ACCELERATORS↗